Anti-PD1 therapy outcome can be predicted by pre-therapy IFN-I responsiveness of Teff cells

Related Experiment Video

Updated: Aug 1, 2025

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.0K

Melanie Grandits1, Jitesh Chauhan1,2, Heather J Bax1,2

  • 1St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London, UK.

Allergy
|April 29, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function09:26

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

14.1K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.8K

Related Concept Videos